Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A clinical trial

Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A clinical trial

© 2018 American Medical Association. IMPORTANCE Cotargeting the mammalian target of rapamycin pathway and estrogen receptor may prevent or delay endocrine resistance in patients receiving first-line treatment for advanced breast cancer. OBJECTIVE To investigate the combination of everolimus plus end...

Full description

Saved in:

Bibliographic Details
Main Authors:	Melanie Royce, Thomas Bachelot, Cristian Villanueva, Mustafa Özgüroglu, Sergio J. Azevedo, Felipe Melo Cruz, Marc Debled, Roberto Hegg, Tatsuya Toyama, Carla Falkson, Joon Jeong, Vichien Srimuninnimit, William J. Gradishar, Christina Arce, Antonia Ridolfi, Chinjune Lin, Fatima Cardoso
Other Authors:	Champalimaud Foundation
Format:	Article
Published:	2019
Subjects:	Biochemistry, Genetics and Molecular Biology Medicine
Online Access:	https://repository.li.mahidol.ac.th/handle/123456789/45128
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Mahidol University

Similar Items

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2
by: Shinzaburo Noguchi, et al.
Published: (2018)

Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2
by: Kathleen I. Pritchard, et al.
Published: (2018)

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2
by: H. S. Rugo, et al.
Published: (2018)

Epidermal growth factor receptor mutation status in the treatment of non-small cell lung cancer: Lessons learned
by: Dae Ho Lee, et al.
Published: (2018)

Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: From bench to clinical use
by: Yohei Sotomi, et al.
Published: (2018)

Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: From bench to clinical use
by: Yohei Sotomi, et al.
Published: (2018)

Association between estrogen receptor concentration in breast cancer tissue and bone mineral density
by: Sutin Sriussadaporn, et al.
Published: (2018)

The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
by: Pannipa Suwannasom, et al.
Published: (2018)

The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
by: Suwannasom P., et al.
Published: (2017)

Real-World Comparison of Clinical Outcomes of Patients who Received New Generation Platinum Chromium Everolimus-Eluting Stent versus Cobalt Chromium Everolimus-Eluting Stent
by: Li, R., et al.
Published: (2016)

Immunoregulatory Property of C-Type Lectin-Like Receptors in Fibrosing Interstitial Lung Diseases
by: Is Effendi, Wiwin, et al.

Investigations of the scavenger receptor class A and complement receptor 3 - Two pattern recognition receptors
by: GOH WEE KANG, JASON
Published: (2011)

Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor
by: Lau, A.J, et al.
Published: (2020)

Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells
by: Chiong, E., et al.
Published: (2016)

CHIMERIC ANTIGEN RECEPTOR BASED ON T CELL RECEPTOR LIKE ANTIBODY
by: WU LING
Published: (2020)

The Cannabinoid Receptors
Published: (2017)

MGlu receptors
Published: (2020)

Controversial endocrine interventions for the aged
by: Leow M.K.S., et al.
Published: (2020)

Evidence-Based Endocrine Surgery
by: Goh, Xueying, et al.
Published: (2022)

Classification of Endocrine Tumors of the Pancreas
by: Mukherjee, JJ, et al.
Published: (2021)

Structural modules for receptor dimerization in the S-locus receptor kinase extracellular domain
by: Sushma Naithani, et al.
Published: (2018)

Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax
by: Jakub Gruszczyk, et al.
Published: (2019)

Studies of lectin receptors of rat microglia in culture: Receptor distribution and internalization
by: Wu, C.H., et al.
Published: (2012)

Studies of lectin receptors of rat microglia in culture: Receptor distribution and internalization
by: Wu, C.H., et al.
Published: (2016)

Conformation of neuropeptide Y receptor antagonists: Structural implications in receptor selectivity
by: Jois, S.D.S., et al.
Published: (2014)

REGIONAL AND CELLULAR LOCALIZATION OF NR3 SUBUNITS OF THE NMDA RECEPTOR AND REGULATION OF THEIR INTRACELLULAR DISTRIBUTION IN RESPONSE TO DOPAMINE RECEPTOR AND NMDA RECEPTOR AGONISTS
by: WEE SIAW LING, KAREN
Published: (2011)

Functional Interactions between the Progesterone Receptor and Estrogen Receptor in Breast Cancer Cells
by: ZHENG ZEYI
Published: (2010)

Leukotriene receptor antagonists
by: Van Bever, H.P.S.
Published: (2014)

Clinical Use of Everolimus-eluting Bioresorbable Vascular Scaffold (BVS) In Treating Coronary Artery Disease
by: Liang, M, et al.
Published: (2016)

Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation
by: Cibrik, D., et al.
Published: (2016)

Randomized Trial of Everolimus-Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation
by: Cibrik, Diane, et al.
Published: (2022)

Multiple endocrine neoplasia type 2
by: Loke, K.Y.
Published: (2013)

Clinical Manifestation of Endocrine Tumors of the Pancreas
by: Lee, KO
Published: (2021)

Differential effect of meclizine on the activity of human pregnane X receptor and constitutive androstane receptor
by: Lau, A.J, et al.
Published: (2020)

Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study
by: Peveling-Oberhag, J., et al.
Published: (2014)

Initial experience in the clinical use of everolimus-eluting bioresorbable vascular scaffold (BVS) in a single institution
by: Liang, M., et al.
Published: (2014)

Dual activation of estrogen receptor a and aryl hydrocarbon receptor by the prenylflavone, Icaritin restrict breast cancer cell growth and destabilize estrogen receptor a protein
by: TIONG CHI TZE
Published: (2011)

Characterisation of Toll-Like receptor 8 as a new innate immune receptor for Mycobacterium tuberculosis
by: OH SEEN HUEY, OLIVIA
Published: (2012)

Differential Global Effects of Selective Estrogen Receptor Modulators on Estrogen Receptor Binding and Transcriptional Regulation
by: LEE YEW KOK
Published: (2011)

Characterization of progesterone receptor isoform-selective activities of progesterone receptor modulators in breast cancer cells.
by: Leo, Joyce Ching Li.
Published: (2008)